Westmore · UDRP DecisionSarl-cerballiance.com
The Panel ordered transfer of <sarl-cerballiance.com>. It found the domain confusingly similar because it incorporated the CERBALLIANCE mark in its entirety, with the addition of “sarl” not preventing confusing similarity. The Complainant established an unrebutted prima facie case that the Respondent lacked rights or legitimate interests, while the domain’s combination of the mark with a French company-form designation created a risk of implied affiliation. Bad faith was established through passive holding and prior use for PPC links, including links to the Complainant’s direct competitors. The Panel also noted that the Respondent’s address corresponded to one of the Complainant’s laboratories.
The timeline behind sarl-cerballiance.com
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
The decision illustrates how a domain combining an entire trademark with a corporate-form designation can simultaneously satisfy confusing similarity, create an implied-affiliation problem under the second element, and strengthen the inference of targeting under the third element. The case also combines two recognized bad-faith patterns—passive holding and monetized PPC use—with an unusually direct contextual link: the Respondent’s address corresponded to one of the Complainant’s laboratories.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
ARBITRATION AND MEDIATION CENTER ADMINISTRATIVE PANEL DECISION Cerba Healthcare v. Benoit Cerballiance Case No. D2025-3816 1. The Parties The Complainant is Cerba Healthcare, France, represented by Domgate, France. The Respondent is Benoit Cerballiance, France. 2. The Domain Name and Registrar The disputed domain name <sarl-cerballiance.com> is registered with Hosting Concepts B.V. d/b/a Registrar.eu. (the “Registrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on September 19, 2025. On September 19, 2025, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On September 19, 2025, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain name which differed from the named Respondent (Redacted for privacy / Whois Privacy Protection Foundation) and contact information in the Complaint. The Center sent an email communication to the Complainant on September 23, 2025, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amended Complaint on September 25, 2025. The Center verified that the Complaint together with the amended Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on September 26, 2025. In accordance with the Rules, paragraph 5, the due date for Response was October 16, 2025. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on October 22, 2025. page 2 The Center appointed Benjamin Fontaine as the sole panelist in this matter on October 27, 2025. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background The Complainant is CERBA HEALTHCARE, a French company founded in 1967 as a reference lab and operating in the specialized biology market in France and over the world. It is one of the European leaders in specialized medical biology. In 2016, CERBA HEALTHCARE created an important network of laboratories called “CERBALLIANCE”. This network brings together over 600 laboratories in France and Europe (Belgium, Luxembourg, Italy). The Complainant is the owner of several trade marks for CERBALLIANCE, including: - French trade mark CERBALLIANCE No. 4213826 registered on January 22, 2016; - International trade mark CERBALLIANCE No. 1316808, registered on March 9, 2016. The disputed domain name <sarl-cerballiance.com> was registered on July 8, 2025. At the time of the present decision, the disputed domain name resolves to an error page. According to the Complainant, it previously first redirected to a 404 error page, then to a webpage with pay-per-click (“PPC”) links. 5. Parties’ Contentions A. Complainant The Complainant contends that it has satisfied each of the elements required under the Policy for a transfer of the disputed domain name. Notably, the Complainant contends that the disputed domain name <sarl-cerballiance.com> is similar to its earlier trade mark CERBALLIANCE to the point of creating confusion. Indeed, the Complainant contends that the disputed domain name comprises its registered and well-known trade mark CERBALLIANCE, combined with the generic French term “SARL”, which denotes a specific type of company structure and the generic extension .com. Then, the Complainant contends that the Respondent has no rights or legitimate interests in respect of the domain name. The Complainant asserts that that the Respondent did not reply to the cease-and-desist letter sent on July 16, 2025, by the Complainant’s representative. This confirms the lack of rights or legitimate interest and the bad faith of the Respondent. The Complainant contends also that it has never licensed or authorized the Respondent to use its trade mark CERBALLIANCE in any way, and that the Respondent is not known under the name CERBALLIANCE. Third, the Complainant claims that the disputed domain name was registered and is being used in bad faith. The Complainant contends that the Respondent could not ignore the existence of the network and trade marks CERBALLIANCE, when he configured and registered the disputed domain name. Indeed, the choice of a domain name containing the trade mark CERBALLIANCE and the initials SARL is relevant as the Respondent picked up a trade mark he perfectly knew, and added a French generic term corresponding to the legal form of a French company. The Complainant also contends that the disputed domain name first resolved to an error 404 Webador page which can be considered as passive holding and does not exclude a finding of bad faith, and later resolved to a website containing PPC ads generating revenue for the page 3 Respondent. Therefore, the Respondent has intentionally attempted to attract, for commercial gain, Internet users to its website. B. Respondent The Respondent did not reply to the Complainant’s contentions. 6. Discussion and Findings A. Identical or Confusingly Similar It is well accepted that the first element functions primarily as a standing requirement. The standing (or threshold) test for confusing similarity involves a reasoned but relatively straightforward comparison between the Complainant’s trade mark and the disputed domain name. WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition (“WIPO Overview 3.0”), section 1.7. The Complainant has shown rights in respect of a trade mark or service mark for the purposes of the Policy. WIPO Overview 3.0, section 1.2.1. The entirety of the mark is reproduced within the disputed domain name. Accordingly, the disputed domain name is confusingly similar to the mark for the purposes of the Policy. WIPO Overview 3.0, section 1.7. Although the addition of other terms, here “sarl” (a French acronym corresponding to a French company legal form “Société A Responsabilité Limitée”) may bear on assessment of the second and third elements, the Panel finds the addition of such term does not prevent a finding of confusing similarity between the disputed domain name and the mark for the purposes of the Policy. WIPO Overview 3.0, section 1.8. The Panel finds the first element of the Policy has been established. B. Rights or Legitimate Interests Paragraph 4(c) of the Policy provides a list of circumstances in which the Respondent may demonstrate rights or legitimate interests in a disputed domain name. Although the overall burden of proof in UDRP proceedings is on the complainant, panels have recognized that proving a respondent lacks rights or legitimate interests in a domain name may result in the difficult task of “proving a negative”, requiring information that is often primarily within the knowledge or control of the respondent. As such, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this element shifts to the respondent to come forward with relevant evidence demonstrating rights or legitimate interests in the domain name (although the burden of proof always remains on the complainant). If the respondent fails to come forward with such relevant evidence, the complainant is deemed to have satisfied the second element. WIPO Overview 3.0, section 2.1. Having reviewed the available record, the Panel finds the Complainant has established a prima facie case that the Respondent lacks rights or legitimate interests in the disputed domain name. The Respondent has not rebutted the Complainant’s prima facie showing and has not come forward with any relevant evidence demonstrating rights or legitimate interests in the disputed domain name such as those enumerated in the Policy or otherwise. Also, the Panel notes that the composition of the disputed domain name, which associates the Complainant’s trade mark and the indication of a legal form of a company, entails a risk of implied affiliation with the Complainant. WIPO Overview 3.0, section 2.5.1. This reinforces the strong presumption of lack of rights or legitimate interests of the Respondent over the disputed domain name. page 4 The Panel finds the second element of the Policy has been established. C. Registered and Used in Bad Faith The Panel notes that, for the purposes of paragraph 4(a)(iii) of the Policy, paragraph 4(b) of the Policy establishes circumstances, in particular, but without limitation, that, if found by the Panel to be present, shall be evidence of the registration and use of a domain name in bad faith. In this case, the Complaint succeeds, both on the claim of the bad faith passive holding, and that of illegitimate activity, namely pay per click based on the likelihood of confusion with the Complainant’s trade mark. First, panels have found that the non-use of a domain name would not prevent a finding of bad faith under the doctrine of passive holding. WIPO Overview 3.0, section 3.3. Having reviewed the available record, the Panel notes the distinctiveness or reputation of the Complainant’s trade mark, and the composition of the disputed domain name, and finds that in the circumstances of this case the passive holding of the disputed domain name does not prevent a finding of bad faith under the Policy. This strong presumption is reinforced by the fact that the Respondent has an address which corresponds, in fact to that of one of the numerous laboratories held by the Complainant. Second, Panels have held that the use of a domain name containing PPC advertising related to a complainant’s trademark, constitutes bad faith under paragraph 4(b)(iv) of the Policy. Having reviewed the record, the Panel finds the Respondent’s registration and use of the disputed domain name constitutes bad faith under the Policy. In the present case, the Panel notes that the disputed domain name <sarl-cerballiance.com> used to redirect to a page offering PPC links for which the Respondent most likely received some commercial gains. The Panel notes that such links also corresponded to the websites of direct competitors of the Complainant. The Panel finds that the Respondent used the disputed domain name to intentionally attempt to attract, for commercial gain, Internet users to its website by creating a likelihood of confusion with the Complainant’s trade marks as to the source, sponsorship, affiliation, or endorsement of the Respondent’s website. Therefore, the Panel finds that the Complainant has established the third element of the Policy. 7. Decision For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain name <sarl-cerballiance.com> be transferred to the Complainant. /Benjamin Fontaine/ Benjamin Fontaine Sole Panelist Date: November 10, 2025
Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.
What Westmore sees around sarl-cerballiance.com
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.